Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Abs. Returns |
---|---|---|---|---|
One Week | 2025-05-27 | ₹1,000.00 | ₹990.23 |
-0.98 %
|
Two Week | 2025-05-19 | ₹1,000.00 | ₹984.25 |
-1.57 %
|
1 Month | 2025-05-05 | ₹1,000.00 | ₹990.66 |
-0.93 %
|
Three Months | 2025-03-05 | ₹3,000.00 | ₹3,092.30 |
3.08 %
|
Six Months | 2024-12-05 | ₹6,000.00 | ₹5,914.55 |
-1.42 %
|
One Year | 2024-06-03 | ₹12,000.00 | ₹12,069.84 |
0.58 %
|
Three Year | 2022-06-06 | ₹36,000.00 | ₹49,158.14 |
36.55 %
|
Since Inception | 2021-11-08 | ₹44,000.00 | ₹61,704.57 |
40.24 %
|
Company Name | Sector | Sector Type | Nav(in %) |
---|---|---|---|
Sun Pharmaceutical Industries Limited | Healthcare | Equity | 15.97 |
Dr. Reddy's Laboratories Limited | Healthcare | Equity | 7.20 |
Lupin Limited | Healthcare | Equity | 6.39 |
Apollo Hospitals Enterprise Limited | Healthcare | Equity | 5.63 |
Suven Pharmaceuticals Limited | Healthcare | Equity | 5.49 |
Divi's Laboratories Limited | Healthcare | Equity | 4.49 |
Zydus Lifesciences Limited | Healthcare | Equity | 4.18 |
Max Healthcare Institute Limited | Healthcare | Equity | 3.31 |
Cipla Limited | Healthcare | Equity | 3.15 |
Laurus Labs Limited | Healthcare | Equity | 2.91 |
Syngene International Limited | Healthcare | Equity | 2.65 |
Torrent Pharmaceuticals Limited | Healthcare | Equity | 2.48 |
Alembic Pharmaceuticals Limited | Healthcare | Equity | 2.11 |
Piramal Pharma Limited | Healthcare | Equity | 1.99 |
Orchid Pharma Limited | Healthcare | Equity | 1.98 |
FDC Limited | Healthcare | Equity | 1.79 |
Aurobindo Pharma Limited | Healthcare | Equity | 1.78 |
IPCA Laboratories Limited | Healthcare | Equity | 1.63 |
Healthcare Global Enterprises Limited | Healthcare | Equity | 1.53 |
Biocon Limited | Healthcare | Equity | 1.39 |
GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Equity | 1.37 |
Ajanta Pharma Limited | Healthcare | Equity | 1.34 |
Mankind Pharma Limited | Healthcare | Equity | 1.33 |
Vijaya Diagnostic Centre Limited | Healthcare | Equity | 1.30 |
Caplin Point Laboratories Limited | Healthcare | Equity | 1.27 |
Abbott India Limited | Healthcare | Equity | 1.13 |
JB Chemicals & Pharmaceuticals Limited | Healthcare | Equity | 1.04 |
Shilpa Medicare Limited | Healthcare | Equity | 1.01 |
Fortis Healthcare Limited | Healthcare | Equity | 0.98 |
Alkem Laboratories Limited | Healthcare | Equity | 0.94 |
Rainbow Childrens Medicare Limited | Healthcare | Equity | 0.94 |
Gland Pharma Limited | Healthcare | Equity | 0.93 |
Strides Pharma Science Limited | Healthcare | Equity | 0.86 |
Wockhardt Limited | Healthcare | Equity | 0.74 |
Sanofi India Limited | Healthcare | Equity | 0.70 |
Emcure Pharmaceuticals Limited | Healthcare | Equity | 0.67 |
Supriya Lifescience Limited | Healthcare | Equity | 0.56 |
Sanofi Consumer Healthcare India Limited | Healthcare | Equity | 0.40 |
India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.
Lock-in times for various investment types
Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.
There are two different types of residual maturity.
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Axis Innovation Fund - Regular Plan - Growth |
9.98%
|
27.76%
|
14.42%
|
Canara Robeco Consumer Trends Fund - Regular Plan - Growth |
9.95%
|
34.58%
|
16.44%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
BARODA BNP PARIBAS INDIA CONSUMPTION FUND - REGULAR PLAN - GROWTH |
9.90%
|
31.87%
|
18.46%
|
Aditya Birla Sun Life India Reforms Fund - Growth-Regular Plan |
9.88%
|
18.78%
|
8.95%
|
Bajaj Finserv Banking and PSU Fund - Regular Plan - Growth |
9.60%
|
6.82%
|
9.12%
|
LIC MF Banking and PSU Fund - Regular Plan - Growth |
9.52%
|
11.08%
|
7.19%
|
NIPPON INDIA QUANT FUND - INSTITUTIONAL PLAN - GROWTH |
9.51%
|
2.81%
|
3.05%
|
Mirae Asset Banking and PSU Fund - Regular Plan |
9.47%
|
11.15%
|
5.56%
|
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
ITI Dynamic Bond Fund - Regular Plan - Growth |
9.70%
|
11.07%
|
6.31%
|
ITI Banking and PSU Fund - Regular Plan - Growth |
8.47%
|
10.77%
|
5.88%
|
ITI Small Cap Fund - Regular Plan - Growth |
7.75%
|
47.95%
|
21.26%
|
ITI Conservative Hybrid Fund - Regular Plan - Growth |
7.42%
|
5.34%
|
5.94%
|
ITI Focused Equity Fund - Regular Plan - Growth |
6.98%
|
20.89%
|
21.91%
|
ITI Liquid Fund - Regular Plan - Growth |
6.95%
|
9.96%
|
5.07%
|
ITI Arbitrage Fund - Regular Plan - Growth |
6.95%
|
9.07%
|
4.52%
|
ITI Ultra Short Duration Fund - Regular Plan - Growth |
6.72%
|
9.43%
|
5.22%
|
ITI Overnight Fund - Regular Plan - Growth |
6.20%
|
9.26%
|
4.79%
|
ITI Flexi Cap Fund - Regular Plan - Growth |
6.10%
|
31.36%
|
27.45%
|
Interested in exploring more about JezzMoney Mutual Fund Distributors Software? Submit the form, and we will respond quickly.